Cytek was targeted with trade secret, antitrust, and other claims for allegedly misusing BD’s technology for flow cytometers, which identify, sort, and engineer cells and small particles. BD added copyright and breach claims based on Cytek’s supposed failure to comply with a software license agreement and unauthorized copying of product manuals.
BD’s claims that Cytek breached the agreeement by making unauthorized software copies or using the software beyond the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.